H.R. 2999 · 115th Congress
Patients' Access to Treatments Act of 2017
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 115th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
McKinleySponsor35 cosponsors · 27 D, 8 R
D
Butterfield
GC
D
Connolly
DC
D
Cicilline
JL
D
Langevin
GN
D
Napolitano
TR
D
Ryan
LS
D
Slaughter
CS
R
Smith
MT
D
Takano
SB
D
Bonamici
CP
D
Pingree
KC
D
Clark
KE
D
Ellison
CM
D
Maloney
JM
D
McGovern
AS
D
Schiff
PA
D
Aguilar
AE
D
Eshoo
MP
D
Pocan
PD
D
DeFazio
LB
R
Barletta
PK
R
King
SP
R
Palazzo
KR
D
Rice
DL
D
Loebsack
JR
D
Raskin
BC
R
Comstock
FS
R
Sensenbrenner
RF
R
Frelinghuysen
DK
D
Kildee
JS
D
Speier
TO
D
O’Halleran
RW
R
Wittman
EB
D
Blumenauer
SC
D
Cohen9 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
This bill amends the Public Health Service Act to establish cost sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost sharing structure.
What it does: CRS summary · Introduced in House · Jun 22, 2017
Patients' Access to Treatments Act of 2017
This bill amends the Public Health Service Act to establish cost sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost sharing structure. Such health plans may not impose higher cost sharing requirements, including copayment and coinsurance, for specialty drugs than for other prescription drugs in a nonpreferred brand name drug tier. If a health plan's formulary contains more than one nonpreferred brand name drug tier, the tier with the lowest cost sharing applies.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Patients' Access to Treatments Act of 2017
Latest action (Jun 23, 2017): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Jun 22, 2017
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.